Evidence map›Paper›PMID 35830998›Full record

ArticleSaudi medical journal2022

Clinicopathological features and prevalence of prostate cancer in Aseer, Saudi Arabia.

Hassan M Otifi, Osama M S Abdul-Wahab, Mishari H Al-Shyarba, Majed S S Al Fayi, Abdullah H Al Murea, Elhem Yacoub

Open access · diamondAbstract read
In one paragraph

Article in Saudi medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Assessment of prostate cancer awareness and screening knowledge among men in Najran, Saudi Arabia: a cross-sectional study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  4. Prostate cancer among Saudis: a registry review.Annals of medicine and surgery (2012) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Hassan M OtifiFrom the Department of Pathology (Otifi); from the Department of Surgery (Al-Shyarba), College of Medicine; from the Department of Clinical Laboratory Sciences (Abdul-Wahab, Al Fayi), Faculty of Applied Medical Sciences, King Khalid University, from the Department of Laboratory (Al Murea), Aseer Central Hospital, Abha, Kingdom of Saudi Arabia, and from the Specialized Unit of Mycoplasmas, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development (Yacoub), Institut Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Osama M S Abdul-WahabFrom the Department of Pathology (Otifi); from the Department of Surgery (Al-Shyarba), College of Medicine; from the Department of Clinical Laboratory Sciences (Abdul-Wahab, Al Fayi), Faculty of Applied Medical Sciences, King Khalid University, from the Department of Laboratory (Al Murea), Aseer Central Hospital, Abha, Kingdom of Saudi Arabia, and from the Specialized Unit of Mycoplasmas, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development (Yacoub), Institut Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Mishari H Al-ShyarbaFrom the Department of Pathology (Otifi); from the Department of Surgery (Al-Shyarba), College of Medicine; from the Department of Clinical Laboratory Sciences (Abdul-Wahab, Al Fayi), Faculty of Applied Medical Sciences, King Khalid University, from the Department of Laboratory (Al Murea), Aseer Central Hospital, Abha, Kingdom of Saudi Arabia, and from the Specialized Unit of Mycoplasmas, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development (Yacoub), Institut Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Majed S S Al FayiFrom the Department of Pathology (Otifi); from the Department of Surgery (Al-Shyarba), College of Medicine; from the Department of Clinical Laboratory Sciences (Abdul-Wahab, Al Fayi), Faculty of Applied Medical Sciences, King Khalid University, from the Department of Laboratory (Al Murea), Aseer Central Hospital, Abha, Kingdom of Saudi Arabia, and from the Specialized Unit of Mycoplasmas, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development (Yacoub), Institut Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Abdullah H Al MureaFrom the Department of Pathology (Otifi); from the Department of Surgery (Al-Shyarba), College of Medicine; from the Department of Clinical Laboratory Sciences (Abdul-Wahab, Al Fayi), Faculty of Applied Medical Sciences, King Khalid University, from the Department of Laboratory (Al Murea), Aseer Central Hospital, Abha, Kingdom of Saudi Arabia, and from the Specialized Unit of Mycoplasmas, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development (Yacoub), Institut Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Elhem YacoubFrom the Department of Pathology (Otifi); from the Department of Surgery (Al-Shyarba), College of Medicine; from the Department of Clinical Laboratory Sciences (Abdul-Wahab, Al Fayi), Faculty of Applied Medical Sciences, King Khalid University, from the Department of Laboratory (Al Murea), Aseer Central Hospital, Abha, Kingdom of Saudi Arabia, and from the Specialized Unit of Mycoplasmas, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development (Yacoub), Institut Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Institut Pasteur de Tunis · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the prevalence and characterize prostate cancer (PC) cases in Aseer, Saudi Arabia.

methodsThis study involved 883 patients who consulted physicians in Aseer Central Hospital, Abha, Saudi Arabia, for prostate issues between the years 2008-2018. All patients underwent digital rectal examination and measurement of their serum prostate-specific antigen levels. For patients who presented abnormal digital rectal examination findings and elevated prostate-specific antigen levels, prostate biopsies were recommended. Specimens were histopathologically examined to differentiate between malignant and benign tumors.

resultsAmong the 883 included patients, 132 (15%) underwent a prostate biopsy and were found to have a tumor. Histopathological examination confirmed malignancy (PC) in 77 (8.7%) patients. The absolute majority of the patients diagnosed with PC (96%) were aged >60 years and almost all of them (92%) were found to have a high prostate-specific antigen level of >4 ng/ml.

conclusionProstate cancer appears to be a serious disease in Aseer, Saudi Arabia. Further studies aimed at determining the causes of this type of cancer and understanding its mechanisms are warranted.

Indexed as

Prostate-Specific AntigenProstatic NeoplasmsBiopsyHumansMalePrevalenceSaudi ArabiaProstate-Specific AntigenAseer regionincidenceprostate cancerSaudi Arabia

Identifiers

PMID35830998
PMCPMC9749688
OpenAlexW4285400590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.